Bimekizumab improves pain, morning stiffness, and fatigue in axial spondyloarthritis patients, with sustained benefits over a ...

AxSpA can bring on plantar fasciitis, which is when inflammation in the heel causes the sole of your foot to hurt. You may ...

The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

New features of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria The concept of nonradiographic axial spondyloarthritis. Recognition of a role of MRI in ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The Assessment of SpondyloArthritis International Society has recently developed new criteria for classification of both axial and peripheral SpA. The new criteria were formulated with the aim of ...

MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Multiple Sclerosis.

Companies like Janssen, Pfizer, UCB, Amgen, and AbbVie are advancing axial spondyloarthritis treatments, focusing on improving symptoms and patient outcomes. LAS ...